Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory
Identifieur interne : 002964 ( Istex/Corpus ); précédent : 002963; suivant : 002965Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory
Auteurs : M. Chitlur ; S. W. Pipe ; M. T. Reding ; C. M. KesslerSource :
- Haemophilia [ 1351-8216 ] ; 2016-01.
Url:
DOI: 10.1111/hae.12775
Links to Exploration step
ISTEX:214BF29225265300E3372E27BE97ED8012C0A65ALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title><author><name sortKey="Chitlur, M" sort="Chitlur, M" uniqKey="Chitlur M" first="M." last="Chitlur">M. Chitlur</name><affiliation><mods:affiliation>Wayne State University, Children's Hospital of Michigan, Detroit, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence: Meera Chitlur, Associate Professor of Pediatrics, Wayne State University School of Medicine, Director, Hemophilia Treatment Center and Hemostasis Program, Children's Hospital of Michigan, 3901, Beaubien Blvd, Detroit, MI 48201, USA.Tel.: 313 745 5515; fax: 313 745 5237;e‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: mchitlur@med.wayne.edu</mods:affiliation></affiliation></author><author><name sortKey="Pipe, S W" sort="Pipe, S W" uniqKey="Pipe S" first="S. W." last="Pipe">S. W. Pipe</name><affiliation><mods:affiliation>University of Michigan, MI, Ann Arbor, USA</mods:affiliation></affiliation></author><author><name sortKey="Reding, M T" sort="Reding, M T" uniqKey="Reding M" first="M. T." last="Reding">M. T. Reding</name><affiliation><mods:affiliation>University of Minnesota, MN, Minneapolis, USA</mods:affiliation></affiliation></author><author><name sortKey="Kessler, C M" sort="Kessler, C M" uniqKey="Kessler C" first="C. M." last="Kessler">C. M. Kessler</name><affiliation><mods:affiliation>Georgetown University Medical Center, DC, Washington, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:214BF29225265300E3372E27BE97ED8012C0A65A</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1111/hae.12775</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-Q5JTCJ4Z-C/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002964</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002964</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title><author><name sortKey="Chitlur, M" sort="Chitlur, M" uniqKey="Chitlur M" first="M." last="Chitlur">M. Chitlur</name><affiliation><mods:affiliation>Wayne State University, Children's Hospital of Michigan, Detroit, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>Correspondence: Meera Chitlur, Associate Professor of Pediatrics, Wayne State University School of Medicine, Director, Hemophilia Treatment Center and Hemostasis Program, Children's Hospital of Michigan, 3901, Beaubien Blvd, Detroit, MI 48201, USA.Tel.: 313 745 5515; fax: 313 745 5237;e‐mail:</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: mchitlur@med.wayne.edu</mods:affiliation></affiliation></author><author><name sortKey="Pipe, S W" sort="Pipe, S W" uniqKey="Pipe S" first="S. W." last="Pipe">S. W. Pipe</name><affiliation><mods:affiliation>University of Michigan, MI, Ann Arbor, USA</mods:affiliation></affiliation></author><author><name sortKey="Reding, M T" sort="Reding, M T" uniqKey="Reding M" first="M. T." last="Reding">M. T. Reding</name><affiliation><mods:affiliation>University of Minnesota, MN, Minneapolis, USA</mods:affiliation></affiliation></author><author><name sortKey="Kessler, C M" sort="Kessler, C M" uniqKey="Kessler C" first="C. M." last="Kessler">C. M. Kessler</name><affiliation><mods:affiliation>Georgetown University Medical Center, DC, Washington, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Haemophilia</title><title level="j" type="alt">HAEMOPHILIA</title><idno type="ISSN">1351-8216</idno><idno type="eISSN">1365-2516</idno><imprint><biblScope unit="vol">22</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="15">15</biblScope><biblScope unit="page" to="19">19</biblScope><biblScope unit="page-count">5</biblScope><date type="published" when="2016-01">2016-01</date></imprint><idno type="ISSN">1351-8216</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1351-8216</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>M. Chitlur</name><affiliations><json:string>Wayne State University, Children's Hospital of Michigan, Detroit, USA</json:string><json:string>Correspondence: Meera Chitlur, Associate Professor of Pediatrics, Wayne State University School of Medicine, Director, Hemophilia Treatment Center and Hemostasis Program, Children's Hospital of Michigan, 3901, Beaubien Blvd, Detroit, MI 48201, USA.Tel.: 313 745 5515; fax: 313 745 5237;e‐mail:</json:string><json:string>E-mail: mchitlur@med.wayne.edu</json:string></affiliations></json:item><json:item><name>S. W. Pipe</name><affiliations><json:string>University of Michigan, MI, Ann Arbor, USA</json:string></affiliations></json:item><json:item><name>M. T. Reding</name><affiliations><json:string>University of Minnesota, MN, Minneapolis, USA</json:string></affiliations></json:item><json:item><name>C. M. Kessler</name><affiliations><json:string>Georgetown University Medical Center, DC, Washington, USA</json:string></affiliations></json:item></author><articleId><json:string>HAE12775</json:string></articleId><arkIstex>ark:/67375/WNG-Q5JTCJ4Z-C</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>editorial</json:string></originalGenre><qualityIndicators><score>5.739</score><pdfWordCount>3727</pdfWordCount><pdfCharCount>24642</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>5</pdfPageCount><pdfPageSize>595.276 x 788.031 pts</pdfPageSize><pdfWordsPerPage>745</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>1</abstractWordCount><abstractCharCount>0</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title><genre><json:string>editorial</json:string></genre><host><title>Haemophilia</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-2516</json:string></doi><issn><json:string>1351-8216</json:string></issn><eissn><json:string>1365-2516</json:string></eissn><publisherId><json:string>HAE</json:string></publisherId><volume>22</volume><issue>1</issue><pages><first>15</first><last>19</last><total>5</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Editorial</value></json:item><json:item><value>Editorials</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-Q5JTCJ4Z-C</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - hematology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - cardiovascular system & hematology</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Genetics(clinical)</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Hematology</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string></scopus></categories><publicationDate>2016</publicationDate><copyrightDate>2016</copyrightDate><doi><json:string>10.1111/hae.12775</json:string></doi><id>214BF29225265300E3372E27BE97ED8012C0A65A</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-Q5JTCJ4Z-C/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-Q5JTCJ4Z-C/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-Q5JTCJ4Z-C/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher ref="https://scientific-publisher.data.istex.fr/ark:/67375/H02-QW5Q88H5-V">Wiley Publishing Ltd</publisher><availability><licence>© 2016 John Wiley & Sons Ltd</licence></availability><date type="published" when="2016-01"></date></publicationStmt><notesStmt><note type="content-type" subtype="editorial" source="editorial" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-STW636XV-K">editorial</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="editorial"><analytic><title level="a" type="main">Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title><author xml:id="author-0000" role="corresp"><persName><forename type="first">M.</forename><surname>Chitlur</surname></persName><affiliation><orgName type="division">Wayne State University</orgName>
<orgName type="institution">Children's Hospital of Michigan</orgName>
<address><settlement>Detroit</settlement>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">S. W.</forename><surname>Pipe</surname></persName><affiliation><orgName type="institution">University of Michigan</orgName>
<address><settlement>Ann Arbor</settlement>
<region>MI</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">M. T.</forename><surname>Reding</surname></persName><affiliation><orgName type="institution">University of Minnesota</orgName>
<address><settlement>Minneapolis</settlement>
<region>MN</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">C. M.</forename><surname>Kessler</surname></persName><affiliation><orgName type="institution">Georgetown University Medical Center</orgName>
<address><settlement>Washington</settlement>
<region>DC</region>
<country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><idno type="istex">214BF29225265300E3372E27BE97ED8012C0A65A</idno><idno type="ark">ark:/67375/WNG-Q5JTCJ4Z-C</idno><idno type="DOI">10.1111/hae.12775</idno><idno type="unit">HAE12775</idno><idno type="toTypesetVersion">file:HAE.HAE12775.pdf</idno></analytic><monogr><title level="j" type="main">Haemophilia</title><title level="j" type="alt">HAEMOPHILIA</title><idno type="pISSN">1351-8216</idno><idno type="eISSN">1365-2516</idno><idno type="book-DOI">10.1111/(ISSN)1365-2516</idno><idno type="book-part-DOI">10.1111/hae.2016.22.issue-1</idno><idno type="product">HAE</idno><imprint><biblScope unit="vol">22</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="15">15</biblScope><biblScope unit="page" to="19">19</biblScope><biblScope unit="page-count">5</biblScope><date type="published" when="2016-01"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><textClass><keywords rend="articleCategory"><term>Editorial</term></keywords><keywords rend="tocHeading1"><term>Editorials</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-Q5JTCJ4Z-C/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component type="serialArticle" version="2.0" xml:id="hae12775" xml:lang="en"><header><publicationMeta level="product"><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2516</doi><issn type="print">1351-8216</issn><issn type="electronic">1365-2516</issn><idGroup><id type="product" value="HAE"></id></idGroup><titleGroup><title sort="HAEMOPHILIA" type="main">Haemophilia</title><title type="short">Haemophilia</title></titleGroup></publicationMeta><publicationMeta level="part" position="10"><doi origin="wiley">10.1111/hae.2016.22.issue-1</doi><copyright ownership="publisher">© 2016 John Wiley & Sons Ltd</copyright><numberingGroup><numbering type="journalVolume" number="22">22</numbering><numbering type="journalIssue">1</numbering></numberingGroup><coverDate startDate="2016-01">January 2016</coverDate></publicationMeta><publicationMeta level="unit" position="40" status="forIssue" type="editorial"><doi>10.1111/hae.12775</doi><idGroup><id type="unit" value="HAE12775"></id></idGroup><countGroup><count number="5" type="pageTotal"></count></countGroup><titleGroup><title type="articleCategory">Editorial</title><title type="tocHeading1">Editorials</title></titleGroup><copyright ownership="publisher">© 2016 John Wiley & Sons Ltd</copyright><eventGroup><event date="2015-06-14" type="manuscriptAccepted"></event><event agent="SPS" date="2015-06-29" type="xmlCreated"></event><event type="firstOnline" date="2016-01-26"></event><event type="publishedOnlineFinalForm" date="2016-01-26"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:5.0.6 mode:FullText" date="2017-02-09"></event></eventGroup><numberingGroup><numbering type="pageFirst">15</numbering><numbering type="pageLast">19</numbering></numberingGroup><correspondenceTo><lineatedText><line>Correspondence: Meera Chitlur, Associate Professor of Pediatrics, Wayne State University School of Medicine, Director, Hemophilia Treatment Center and Hemostasis Program, Children's Hospital of Michigan, 3901, Beaubien Blvd, Detroit, MI 48201, USA.</line><line>Tel.: 313 745 5515; fax: 313 745 5237;</line><line>e‐mail: <email>mchitlur@med.wayne.edu</email></line></lineatedText></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:HAE.HAE12775.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title><title type="shortAuthors">Editorial</title></titleGroup><creators><creator affiliationRef="#hae12775-aff-0001" corresponding="yes" creatorRole="author" xml:id="hae12775-cr-0001"><personName><givenNames>M.</givenNames> <familyName>Chitlur</familyName></personName></creator><creator affiliationRef="#hae12775-aff-0002" creatorRole="author" xml:id="hae12775-cr-0002"><personName><givenNames>S. W.</givenNames> <familyName>Pipe</familyName></personName></creator><creator affiliationRef="#hae12775-aff-0003" creatorRole="author" xml:id="hae12775-cr-0003"><personName><givenNames>M. T.</givenNames> <familyName>Reding</familyName></personName></creator><creator affiliationRef="#hae12775-aff-0004" creatorRole="author" xml:id="hae12775-cr-0004"><personName><givenNames>C. M.</givenNames> <familyName>Kessler</familyName></personName></creator></creators><affiliationGroup><affiliation countryCode="US" type="organization" xml:id="hae12775-aff-0001"><orgDiv>Wayne State University</orgDiv> <orgName>Children's Hospital of Michigan</orgName> <address><city>Detroit</city> <country>USA</country></address></affiliation><affiliation countryCode="US" type="organization" xml:id="hae12775-aff-0002"><orgName>University of Michigan</orgName> <address><city>Ann Arbor</city> <countryPart>MI</countryPart> <country>USA</country></address></affiliation><affiliation countryCode="US" type="organization" xml:id="hae12775-aff-0003"><orgName>University of Minnesota</orgName> <address><city>Minneapolis</city> <countryPart>MN</countryPart> <country>USA</country></address></affiliation><affiliation countryCode="US" type="organization" xml:id="hae12775-aff-0004"><orgName>Georgetown University Medical Center</orgName> <address><city>Washington</city> <countryPart>DC</countryPart> <country>USA</country></address></affiliation></affiliationGroup><fundingInfo><fundingAgency fundRefName="Novo Nordisk" funderDoi="10.13039/501100004191">Novo Nordisk Inc</fundingAgency></fundingInfo></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Chitlur</namePart><affiliation>Wayne State University, Children's Hospital of Michigan, Detroit, USA</affiliation><affiliation>Correspondence: Meera Chitlur, Associate Professor of Pediatrics, Wayne State University School of Medicine, Director, Hemophilia Treatment Center and Hemostasis Program, Children's Hospital of Michigan, 3901, Beaubien Blvd, Detroit, MI 48201, USA.Tel.: 313 745 5515; fax: 313 745 5237;e‐mail:</affiliation><affiliation>E-mail: mchitlur@med.wayne.edu</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S. W.</namePart><namePart type="family">Pipe</namePart><affiliation>University of Michigan, MI, Ann Arbor, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M. T.</namePart><namePart type="family">Reding</namePart><affiliation>University of Minnesota, MN, Minneapolis, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C. M.</namePart><namePart type="family">Kessler</namePart><affiliation>Georgetown University Medical Center, DC, Washington, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="editorial" displayLabel="editorial" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-STW636XV-K">editorial</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><dateIssued encoding="w3cdtf">2016-01</dateIssued><dateCreated encoding="w3cdtf">2015-06-29</dateCreated><dateValid encoding="w3cdtf">2015-06-14</dateValid><copyrightDate encoding="w3cdtf">2016</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><note type="funding">Novo Nordisk Inc</note><relatedItem type="host"><titleInfo><title>Haemophilia</title></titleInfo><titleInfo type="abbreviated"><title>Haemophilia</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Editorial</topic><topic>Editorials</topic></subject><identifier type="ISSN">1351-8216</identifier><identifier type="eISSN">1365-2516</identifier><identifier type="DOI">10.1111/(ISSN)1365-2516</identifier><identifier type="PublisherID">HAE</identifier><part><date>2016</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>15</start><end>19</end><total>5</total></extent></part></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0001"><titleInfo><title>Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Baudo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Collins</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Huth‐Kuhne</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Baudo F, Collins P, Huth‐Kuhne A et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012; 120: 39–46.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>39</start><end>46</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>39</start><end>46</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0002"><titleInfo><title>Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Collins</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Baudo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Knoebl</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Collins P, Baudo F, Knoebl P et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood 2012; 120: 47–55.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>47</start><end>55</end></extent></part><relatedItem type="host"><titleInfo><title>Blood</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>47</start><end>55</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0003"><titleInfo><title>Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)</title></titleInfo><name type="personal"><namePart type="given">P</namePart><namePart type="family">Knoebl</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Marco</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Baudo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Knoebl P, Marco P, Baudo F et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012; 10: 622–31.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>622</start><end>31</end></extent></part><relatedItem type="host"><titleInfo><title>J Thromb Haemost</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>622</start><end>31</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0004"><titleInfo><title>Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Tengborn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Baudo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Huth‐Kuhne</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tengborn L, Baudo F, Huth‐Kuhne A et al. Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG 2012; 119: 1529–37.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>1529</start><end>37</end></extent></part><relatedItem type="host"><titleInfo><title>BJOG</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>119</number></detail><extent unit="pages"><start>1529</start><end>37</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0005"><titleInfo><title>US experience with recombinant factor VIIa (rFVIIa) for surgery in acquired hemophilia (AH): analysis from the Hemophilia and Thrombosis Research Society (HTRS) Registry</title></titleInfo><name type="personal"><namePart type="given">HAB</namePart><namePart type="family">Al‐Mondhiry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AD</namePart><namePart type="family">Ma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CM</namePart><namePart type="family">Kessler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Fisher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RZ</namePart><namePart type="family">Gut</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DL</namePart><namePart type="family">Cooper</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Al‐Mondhiry HAB, Ma AD, Kessler CM, Fisher M, Gut RZ, Cooper DL. US experience with recombinant factor VIIa (rFVIIa) for surgery in acquired hemophilia (AH): analysis from the Hemophilia and Thrombosis Research Society (HTRS) Registry. ASH Ann Meet Abs 2012; 120: 3372.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>3372</start></extent></part><relatedItem type="host"><titleInfo><title>ASH Ann Meet Abs</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>3372</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0006"><titleInfo><title>The Hemostasis and Thrombosis Research Society (HTRS) Registry Study of acquired hemophilia: assessment of AH patient demographics in the US</title></titleInfo><name type="personal"><namePart type="given">CM</namePart><namePart type="family">Kessler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AD</namePart><namePart type="family">Ma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HAB</namePart><namePart type="family">Al‐Mondhiry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Fisher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RZ</namePart><namePart type="family">Gut</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DL</namePart><namePart type="family">Cooper</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kessler CM, Ma AD, Al‐Mondhiry HAB, Fisher M, Gut RZ, Cooper DL. The Hemostasis and Thrombosis Research Society (HTRS) Registry Study of acquired hemophilia: assessment of AH patient demographics in the US. ASH Ann Meet Abs 2012; 120: 4625.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>4625</start></extent></part><relatedItem type="host"><titleInfo><title>ASH Ann Meet Abs</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>4625</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0007"><titleInfo><title>Use of recombinant factor VIIa (rFVIIa) for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society (HTRS) Registry AH Study</title></titleInfo><name type="personal"><namePart type="given">AD</namePart><namePart type="family">Ma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CM</namePart><namePart type="family">Kessler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HAB</namePart><namePart type="family">Al‐Mondhiry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Fisher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RZ</namePart><namePart type="family">Gut</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DL</namePart><namePart type="family">Cooper</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ma AD, Kessler CM, Al‐Mondhiry HAB, Fisher M, Gut RZ, Cooper DL. Use of recombinant factor VIIa (rFVIIa) for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society (HTRS) Registry AH Study. ASH Ann Meet Abs 2012; 120: 4624.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>4624</start></extent></part><relatedItem type="host"><titleInfo><title>ASH Ann Meet Abs</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>120</number></detail><extent unit="pages"><start>4624</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0008"><titleInfo><title>Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents</title></titleInfo><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Poon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Zotz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Di Minno</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ZS</namePart><namePart type="family">Abrams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Knudsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Laurian</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents. Semin Hematol 2006; 43(1 Suppl. 1): S33–6.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><detail type="issue"><caption>no.</caption><number>1 Suppl. 1</number></detail><extent unit="pages"><start>S33</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>Semin Hematol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><detail type="issue"><caption>no.</caption><number>1 Suppl. 1</number></detail><extent unit="pages"><start>S33</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0009"><titleInfo><title>Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Mariani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Napolitano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Dolce</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mariani G, Napolitano M, Dolce A et al. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation. Thromb Haemost 2013; 109: 238–47.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>238</start><end>47</end></extent></part><relatedItem type="host"><titleInfo><title>Thromb Haemost</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>109</number></detail><extent unit="pages"><start>238</start><end>47</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0010"><titleInfo><title>Invasive procedures and minor surgery in factor VII deficiency</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Mariani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Dolce</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Napolitano</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mariani G, Dolce A, Napolitano M et al. Invasive procedures and minor surgery in factor VII deficiency. Haemophilia 2012; 18: e63–5.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>e63</start><end>5</end></extent></part><relatedItem type="host"><titleInfo><title>Haemophilia</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>e63</start><end>5</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0011"><titleInfo><title>Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Napolitano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Giansily‐Blaizot</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Dolce</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Napolitano M, Giansily‐Blaizot M, Dolce A et al. Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Haematologica 2013; 98: 538–44.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>538</start><end>44</end></extent></part><relatedItem type="host"><titleInfo><title>Haematologica</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>98</number></detail><extent unit="pages"><start>538</start><end>44</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0012"><titleInfo><title>Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two‐year, randomized, double‐blind, placebo‐controlled trial</title></titleInfo><name type="personal"><namePart type="given">JR</namePart><namePart type="family">O'Dell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Leff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Paulsen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">O'Dell JR, Leff R, Paulsen G et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two‐year, randomized, double‐blind, placebo‐controlled trial. Arthritis Rheum 2002; 46: 1164–70.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>1164</start><end>70</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>1164</start><end>70</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0013"><titleInfo><title>Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study</title></titleInfo><name type="personal"><namePart type="given">I</namePart><namePart type="family">Jennings</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Kitchen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TA</namePart><namePart type="family">Woods</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FE</namePart><namePart type="family">Preston</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Uk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jennings I, Kitchen S, Woods TA, Preston FE, Uk N. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 2003; 1: 2603–8.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>2603</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Thromb Haemost</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>2603</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0014"><titleInfo><title>Diagnosis and classification of factor XIII deficiencies</title></titleInfo><name type="personal"><namePart type="given">HP</namePart><namePart type="family">Kohler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ichinose</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Seitz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kohler HP, Ichinose A, Seitz R et al. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 9: 1404–6.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1404</start><end>6</end></extent></part><relatedItem type="host"><titleInfo><title>J Thromb Haemost</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1404</start><end>6</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0015"><titleInfo><title>Benefits and adverse drug experiences during long‐term methotrexate treatment of 248 psoriatics</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Nyfors</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nyfors A. Benefits and adverse drug experiences during long‐term methotrexate treatment of 248 psoriatics. Dan Med Bull 1978; 25: 208–11.</note><part><date>1978</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>208</start><end>11</end></extent></part><relatedItem type="host"><titleInfo><title>Dan Med Bull</title></titleInfo><part><date>1978</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>208</start><end>11</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0016"><titleInfo><title>A simple, quick one‐step ELISA assay for the determination of complex plasma factor XIII (A2B2)</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Katona</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Haramura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Karpati</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Fachet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Muszbek</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Katona E, Haramura G, Karpati L, Fachet J, Muszbek L. A simple, quick one‐step ELISA assay for the determination of complex plasma factor XIII (A2B2). Thromb Haemost 2000; 83: 268–73.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>268</start><end>73</end></extent></part><relatedItem type="host"><titleInfo><title>Thromb Haemost</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>268</start><end>73</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0017"><titleInfo><title>Enzyme‐linked immunosorbent assay for the determination of blood coagulation factor XIII A‐subunit in plasma and in cell lysates</title></titleInfo><name type="personal"><namePart type="given">EE</namePart><namePart type="family">Katona</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Ajzner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Toth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Karpati</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Muszbek</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Katona EE, Ajzner E, Toth K, Karpati L, Muszbek L. Enzyme‐linked immunosorbent assay for the determination of blood coagulation factor XIII A‐subunit in plasma and in cell lysates. J Immunol Methods 2001; 258: 127–35.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>258</number></detail><extent unit="pages"><start>127</start><end>35</end></extent></part><relatedItem type="host"><titleInfo><title>J Immunol Methods</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>258</number></detail><extent unit="pages"><start>127</start><end>35</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0018"><titleInfo><title>Steps towards an effective treatment strategy in congenital factor VII deficiency</title></titleInfo><name type="personal"><namePart type="given">G</namePart><namePart type="family">Mariani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Lapecorella</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Dolce</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mariani G, Lapecorella M, Dolce A. Steps towards an effective treatment strategy in congenital factor VII deficiency. Semin Hematol 2006; 43(1 Suppl. 1): S42–7.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><detail type="issue"><caption>no.</caption><number>1 Suppl. 1</number></detail><extent unit="pages"><start>S42</start><end>7</end></extent></part><relatedItem type="host"><titleInfo><title>Semin Hematol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><detail type="issue"><caption>no.</caption><number>1 Suppl. 1</number></detail><extent unit="pages"><start>S42</start><end>7</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0019"><titleInfo><title>They're not your Daddy's Inherited Platelet Disorders anymore</title></titleInfo><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Lambert</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Poncz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lambert MP, Poncz M. They're not your Daddy's Inherited Platelet Disorders anymore. J Thromb Haemost 2013; 11: 2037–8.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>2037</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Thromb Haemost</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>2037</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0020"><titleInfo><title>Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Rau</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rau R. Efficacy of methotrexate in comparison to biologics in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28(5 Suppl. 61): S58–64.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><detail type="issue"><caption>no.</caption><number>5 Suppl. 61</number></detail><extent unit="pages"><start>S58</start><end>64</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Exp Rheumatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><detail type="issue"><caption>no.</caption><number>5 Suppl. 61</number></detail><extent unit="pages"><start>S58</start><end>64</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0021"><titleInfo><title>Westbury SK, Turro E, Greene D et al. Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders. Genome Med 2015; 7: 36.</title></titleInfo><note type="citation/reference">Westbury SK, Turro E, Greene D et al. Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders. Genome Med 2015; 7: 36.</note><name type="personal"><namePart type="given">SK</namePart><namePart type="family">Westbury</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Turro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Greene</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><part><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>36</start></extent></part></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0022"><titleInfo><title>Methotrexate in rheumatoid arthritis: a quarter century of development</title></titleInfo><name type="personal"><namePart type="given">ME</namePart><namePart type="family">Weinblatt</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weinblatt ME. Methotrexate in rheumatoid arthritis: a quarter century of development. Trans Am Clin Climatol Assoc 2013; 124: 16–25.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>124</number></detail><extent unit="pages"><start>16</start><end>25</end></extent></part><relatedItem type="host"><titleInfo><title>Trans Am Clin Climatol Assoc</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>124</number></detail><extent unit="pages"><start>16</start><end>25</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0023"><titleInfo><title>Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial</title></titleInfo><name type="personal"><namePart type="given">HJ</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RF</namePart><namePart type="family">Willkens</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CO</namePart><namePart type="family">Samuelson Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Williams HJ, Willkens RF, Samuelson CO Jr et al. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985; 28: 721–30.</note><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>721</start><end>30</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>721</start><end>30</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0024"><titleInfo><title>The use of central laboratories and remote electronic data capture to risk‐adjust therapy for pediatric acute lymphoblastic leukemia and neuroblastoma</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Devidas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WB</namePart><namePart type="family">London</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Devidas M, London WB, Anderson JR. The use of central laboratories and remote electronic data capture to risk‐adjust therapy for pediatric acute lymphoblastic leukemia and neuroblastoma. Semin Oncol 2010; 37: 53–9.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>53</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Semin Oncol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>53</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="hae12775-cit-0025"><titleInfo><title>Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">van der Heijde</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Klareskog</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Landewe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">van der Heijde D, Klareskog L, Landewe R et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 2007; 56: 3928–39.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>3928</start><end>39</end></extent></part><relatedItem type="host"><titleInfo><title>Arthritis Rheum</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>3928</start><end>39</end></extent></part></relatedItem></relatedItem><identifier type="istex">214BF29225265300E3372E27BE97ED8012C0A65A</identifier><identifier type="ark">ark:/67375/WNG-Q5JTCJ4Z-C</identifier><identifier type="DOI">10.1111/hae.12775</identifier><identifier type="ArticleID">HAE12775</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2016 John Wiley & Sons Ltd© 2016 John Wiley & Sons Ltd</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-14</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-Q5JTCJ4Z-C/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002964 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002964 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:214BF29225265300E3372E27BE97ED8012C0A65A
|texte= Overcoming the diagnostic and monitoring challenges for very rare bleeding disorders in the US: the potential benefits of a centralized laboratory
}}
| This area was generated with Dilib version V0.6.33. |  |